Seedat Y K, Seedat M A, Bhoola R
S Afr Med J. 1977 Apr 2;51(14):461-3.
We conducted an uncontrolled study of the efficacy of prazosin in the treatment of hypertension in 45 patients. In 25 patients only prazosin was used and in 20 patients prazosin was combined with a thiazide diuretic. Control of blood pressure was obtained in 22 of the 25 patients (88%) on prazosin alone, and in all the patients on the combined treatment. Adverse effects occurred in 15 of 25 patients (60%) on prazosin alone, and in 13 of the 20 patients (65%) on combined treatment. However, in 18 patients (40%) adverse effects disappeared or were tolerated with continued therapy. In 10 patients (22%) therapy was stopped because of the adverse effects. The median dose of prazosin was 5,73 mg twice a day. Prazosin is a useful alternative to hydralazine in the treatment of hypertension.
我们对45例高血压患者进行了一项关于哌唑嗪治疗效果的非对照研究。25例患者仅使用哌唑嗪,20例患者将哌唑嗪与噻嗪类利尿剂联合使用。仅使用哌唑嗪的25例患者中有22例(88%)血压得到控制,联合治疗的所有患者血压均得到控制。仅使用哌唑嗪的25例患者中有15例(60%)出现不良反应,联合治疗的20例患者中有13例(65%)出现不良反应。然而,18例患者(40%)的不良反应在持续治疗后消失或可耐受。10例患者(22%)因不良反应而停药。哌唑嗪的中位剂量为每日两次,每次5.73毫克。在高血压治疗中,哌唑嗪是肼屈嗪的一种有用替代药物。